Gopal C. Kundu

9.3k total citations · 2 hit papers
134 papers, 7.3k citations indexed

About

Gopal C. Kundu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gopal C. Kundu has authored 134 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 34 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Gopal C. Kundu's work include Bone and Dental Protein Studies (29 papers), Cancer Cells and Metastasis (17 papers) and Nanoplatforms for cancer theranostics (16 papers). Gopal C. Kundu is often cited by papers focused on Bone and Dental Protein Studies (29 papers), Cancer Cells and Metastasis (17 papers) and Nanoplatforms for cancer theranostics (16 papers). Gopal C. Kundu collaborates with scholars based in India, United States and Portugal. Gopal C. Kundu's co-authors include Anuradha Bulbule, Hema Rangaswami, Ganapati H. Mahabeleshwar, Subha Philip, Goutam Chakraborty, Shalini Jain, Anil B. Mukherjee, Mahadeo Gorain, Dhiraj Kumar and Amit Singh Yadav and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gopal C. Kundu

131 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteopontin: role in cell signaling and cancer progression

2006 576 citations Anuradha Bulbule, Gopal C. Kundu et al. profile →
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer

2024 99 citations Ramesh Butti, Diksha Malhotra et al. profile →

Peers

Countries citing papers authored by Gopal C. Kundu

Since Specialization

Citations

This map shows the geographic impact of Gopal C. Kundu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopal C. Kundu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopal C. Kundu more than expected).

Fields of papers citing papers by Gopal C. Kundu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopal C. Kundu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopal C. Kundu. The network helps show where Gopal C. Kundu may publish in the future.

Co-authorship network of co-authors of Gopal C. Kundu

This figure shows the co-authorship network connecting the top 25 collaborators of Gopal C. Kundu. A scholar is included among the top collaborators of Gopal C. Kundu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopal C. Kundu. Gopal C. Kundu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting and engineering biomarkers for prostate cancer therapy 2025 ·Molecular Aspects of Medicine ·Dhirodatta Senapati, Santosh Kumar Sahoo, (unknown), Suneeta Senapati, Gopal C. Kundu, Subrat Kumar Bhattamisra	1
2	Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives 2025 ·Cancer Drug Resistance ·(unknown), (unknown), (unknown), (unknown), (unknown), Diksha Malhotra, Sujoy Saha, (unknown), Kavita Kumari, Saumya Ranjan Jena, (unknown), P. K. Singh, Gopal C. Kundu	0
3	Rationalizing Defective Biomimetic Ceria: In Vitro Demonstration of a Potential “Trojan Horse” Nanozyme Based‐Platform Leveraging Photo‐Redox Activities for Minimally Invasive Therapy 2024 ·Advanced Materials Technologies ·(unknown), Diksha Malhotra, (unknown), Gopal C. Kundu, Rohit Srivastava, Ajit R. Kulkarni	2
4	Sponging of five tumour suppressor miRNAs by lncRNA-KCNQ1OT1 activates BMPR1A/BMPR1B-ACVR2A/ACVR2B signalling and promotes chemoresistance in hepatocellular carcinoma 2024 ·Cell Death Discovery ·(unknown), (unknown), Sumit Das, Mahadeo Gorain, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhijit Chowdhury, Simanti Datta, Gopal C. Kundu, Soma Banerjee	2
5	Emissive Lipid Nanoparticles as Biophotonic Contrast Agent for Site-Selective Solid Tumor Imaging in Pre-Clinical Models 2024 ·ACS Applied Materials & Interfaces ·Rajendra Prasad, Rohini Kumari, (unknown), Rahul Kumar, Gopal C. Kundu, (unknown), Gaurab Roy, Mahadeo Gorain, Pranjal Chandra	10
6	Poly(d,l-lactide-co-glycolide) Surface-Anchored Biotin-Loaded Irinotecan Nanoparticles for Active Targeting of Colon Cancer 2024 ·ACS Omega ·Prabhanjan Giram, (unknown), Anuradha Bulbule, Amit Singh Yadav, Mahadeo Gorain, (unknown), Gopal C. Kundu, Baijayantimala Garnaik	2
7	Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines 2023 ·Journal of Ethnopharmacology ·(unknown), (unknown), (unknown), (unknown), Gopal C. Kundu, Rajesh N. Gacche	15
8	Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer 2023 ·Oncology Reports ·Ramesh Butti, (unknown), (unknown), Suhail Ahmad, (unknown), Pallavi Parab, (unknown), Soumya Ranjan Mahapatra, Tanuja Shet, Amit Dutt, Sudeep Gupta, Gopal C. Kundu	5
9	Antiproliferative and Apoptotic Potential of Methotrexate Lipid Nanoparticles in A Murine Breast Cancer Model 2022 ·Nanomedicine ·(unknown), Ananya Banerjee, S Anupriya, (unknown), Dhiraj Kumar, Ramesh Butti, Mahadeo Gorain, (unknown), Gopal C. Kundu, Supriya Shidhaye, Srinivas Patnaik	5
10	SMAR1 suppresses the cancer stem cell population via hTERT repression in colorectal cancer cells 2021 ·The International Journal of Biochemistry & Cell Biology ·(unknown), (unknown), Nandaraj Taye, (unknown), Priyanka Firmal, Gopal C. Kundu, Samit Chattopadhyay	1
11	Structural Constraint of Osteopontin Facilitates Efficient Binding to CD44 2021 ·Biomolecules ·(unknown), (unknown), Gopal C. Kundu, Georg F. Weber	11
12	<p>Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer</p> 2019 ·International Journal of Nanomedicine ·(unknown), Amit Singh Yadav, Mahadeo Gorain, Vinay Pawar, Ranveig Braathen, Siegfried Weiß, Bjarne Bogen, Suresh Gosavi, Gopal C. Kundu	78
13	Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma 2016 ·Molecular Cancer Therapeutics ·Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, Chulwon Kim, (unknown), Frank Arfuso, Jae‐Young Um, Alan Prem Kumar, Young‐Chae Chang, Dhiraj Kumar, Gopal C. Kundu, Junji Magae, Boon Cher Goh, Kam M. Hui, Gautam Sethi	82
14	Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytes 2015 ·Cancer Biology & Therapy ·Vishalakshi Nanjappa, Santosh Renuse, Gajanan Sathe, Remya Raja, Nazia Syed, Aneesha Radhakrishnan, Tejaswini Subbannayya, Arun H. Patil, Arivusudar Marimuthu, Nandini A. Sahasrabuddhe, Rafael Guerrero‐Preston, Babu Lal Somani, Bipin G. Nair, Gopal C. Kundu, Thottethodi Subrahmanya Keshava Prasad, Joseph A. Califano, Harsha Gowda, David Sidransky, Akhilesh Pandey, Aditi Chatterjee	28
15	p38 Kinase Is Crucial for Osteopontin-Induced Furin Expression That Supports Cervical Cancer Progression 2010 ·Cancer Research ·Vinit Kumar, Reeti Behera, Kirti Lohite, Swapnil Karnik, Gopal C. Kundu	71
16	Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer 2008 ·Cancer Research ·Shalini Jain, Goutam Chakraborty, Remya Raja, Smita Kale, Gopal C. Kundu	138
17	Osteopontin Promotes Vascular Endothelial Growth Factor–Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms 2008 ·Cancer Research ·Goutam Chakraborty, Shalini Jain, Gopal C. Kundu	223
18	Down‐regulation of osteopontin attenuates breast tumour progression in vivo 2008 ·Journal of Cellular and Molecular Medicine ·Goutam Chakraborty, Shalini Jain, (unknown), Gopal C. Kundu	37
19	Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice 1999 ·Nature Medicine ·Feng Zheng, Gopal C. Kundu, Zhongjian Zhang, Jerrold M. Ward, Francesco J. DeMayo, Anil B. Mukherjee	76
20	Uteroglobin (UG) Suppresses Extracellular Matrix Invasion by Normal and Cancer Cells That Express the High Affinity UG-binding Proteins 1998 ·Journal of Biological Chemistry ·Gopal C. Kundu, Asim K. Mandal, Zhongjian Zhang, (unknown), Anil B. Mukherjee	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact